Bill > HR8624

Introduced Session

Allows the Centers for Medicare & Medicaid Services (CMS) to extend the duration of pass-through status (i.e., additional payment) for certain drugs and devices under the Medicare prospective payment system for hospital outpatient department services. Specifically, the CMS may extend the pass-through status of drugs and devices that received such status during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019) if their cost cannot be accurately calculated due to the effects of COVID-19. The bill's provisions apply to drugs and devices that had pass-through status during any portion of the public health emergency period, including those for which such status has already expired.

AI Summary

Committee Categories

Brad Wenstrup (R)*,  Sanford Bishop (D),  Brian Fitzpatrick (R),  Andy Harris (R),  Richard Hudson (R),  Mike Kelly (R),  Kenny Marchant (R), 

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 10/16/2020)

Official Document